Malignant lymphoproliferative diseases induced by Epstein-Barr Virus in immunodeficient patients, including X-linked, cytogenetic, and familial syndromes.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001260:Ataxia Telangiectasia / Q000276:immunology; D001323:Autoantibodies / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D002869:Chromosome Aberrations; D005260:Female; D008040:Genetic Linkage; D004854:Herpesvirus 4, Human / Q000472:pathogenicity*; D006644:Histiocytes / Q000382:microbiology; D006689:Hodgkin Disease / Q000235:genetics / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate; D007153:Immunologic Deficiency Syndromes / Q000150:complications* / Q000235:genetics; D007165:Immunosuppression Therapy; D007223:Infant; D007244:Infectious Mononucleosis / Q000276:immunology; D016030:Kidney Transplantation; D007694:Killer Cells, Natural / Q000276:immunology; D008206:Lymphatic Diseases / Q000175:diagnosis; D008232:Lymphoproliferative Disorders / Q000209:etiology* / Q000276:immunology; D008297:Male; D051379:Mice; D008875:Middle Aged; D008954:Models, Biological; D011230:Precancerous Conditions / Q000276:immunology; D012737:Sex Factors; D013601:T-Lymphocytes / Q000276:immunology; D014960:X Chromosome
D001323:Autoantibodies